Blab AI
China Orders Meta to Unwind $2 B Manus AI Acquisition, Setting New Regulatory Precedent
On April 27 2026, China’s National Development and Reform Commission (NDRC) ordered Meta Platforms to unwind its $2 billion-plus acquisition of Manus, a Singapore‑based artificial‑intelligence startup founded in Wuhan, China. The order is the first publicly confirmed use of China’s Foreign Investment Security Review (FISR) mechanism to reverse a completed cross‑border AI transaction.
Manus was founded in 2022 by Chinese nationals Xiao Hong and Ji Yichao. The company launched an AI agent in March 2025 that gained rapid attention for its ability to perform complex tasks on top of existing large language models. Unlike many Chinese AI firms, Manus did not build its own foundation model; instead it created an agent framework that could operate with third‑party models.
In mid‑2025 Manus moved its headquarters and about 40 core technical staff from China to Singapore, while roughly 80 employees in China were laid off. The relocation was described by analysts as “Singapore washing.” Meta announced the acquisition in December 2025 and closed the deal shortly thereafter. Neither Manus nor Meta sought Chinese regulatory approval for the relocation or the acquisition.
The Ministry of Commerce opened an investigation in January 2026, shortly after the transaction closed. In March, Manus co‑founders were summoned to Beijing and barred from leaving the country. On April 27, the NDRC issued a formal prohibition order, stating that it would “prohibit foreign investment in the Manus project in accordance with laws and regulations, and has required the parties involved to withdraw the acquisition transaction.” By June, Meta had begun dismantling the deal, halting data sharing and completing an operational separation.
The NDRC’s decision was based on the 2021 Measures for the Security Review of Foreign Investment. Rather than focusing on the legal entity, the commission referred to the “project” and examined where the technology was developed, where the engineering talent was trained, and how intellectual property was transferred out of the original Chinese entity. The order did not claim that Manus was currently operating in China, nor that the technology was subject to an existing export control. Instead, the enforcement rested on the premise that technology created by Chinese nationals on Chinese soil retains a regulatory nexus to China, regardless of subsequent redomiciling or ownership changes.
The Manus case signals a shift toward a “technological nationality” doctrine. Analysts note that Singapore incorporation, Cayman Islands registration, or Delaware incorporation no longer guarantees immunity from Chinese regulatory reach. For in‑house counsel, the lesson is that redomiciling does not extinguish Chinese jurisdiction. Corporate restructuring does not sever the regulatory nexus. If core technology was developed in China or by Chinese nationals who acquired their expertise domestically, Beijing has now demonstrated both the willingness and the mechanism to reach across borders and unwind the transaction after the fact.
The new regulatory framework codified this principle. On June 1 2026, the State Council issued the Regulation on Outbound Investment (State Council Decree No. 837), effective July 1. Article 13 specifically prohibits investors from exporting, using, or transferring goods, technologies, services, or data prohibited from export, including indirect means such as relocating technical personnel overseas, providing cross‑border technical guidance, and arranging overseas training programs. The regulation introduces what commentators call “full‑process supervision,” meaning regulators are concerned not only with market entry or deal consummation but with ongoing operations, risk exposure, and conduct compliance throughout an investment’s lifetime.
The regulation also establishes an outbound investment security review mechanism that mirrors the inbound FISR, giving Beijing statutory authority to punish foreign firms whose home countries restrict Chinese investment. Consequently, a U.S. acquirer of Chinese‑origin AI may trigger review both as an inbound foreign investment under the FISR and as a restricted outbound investment under the new State Council regulation. The compliance question is no longer whether one jurisdiction objects; it is whether either jurisdiction has grounds to act.
For U.S. entities, the Outbound Investment Rule (Executive Order 14105, codified at 31 C.F.R. Part 850) restricts U.S. persons from making covered investments in entities involving Chinese persons in AI‑related sectors. On the Chinese side, the 2025 Catalogue of Technologies Prohibited or Restricted from Export lists core AI techniques, including large‑scale personalized recommendation algorithms. The Manus case demonstrates that both sides can act, creating a dual regulatory exposure.
The unwind of the Manus deal is not an isolated enforcement action but establishes a new baseline. Beijing has demonstrated that it will reach through offshore structures, past corporate reorganizations, and beyond national borders to assert authority over technology it considers Chinese in origin. The new State Council regulation ensures that this authority is not ad hoc. It is statutory, prospective, and enforceable at every stage of an investment’s lifecycle.
For in‑house counsel, the practical takeaway is that any AI‑related transaction touching Chinese‑origin technology, talent, or data now requires a different diligence framework, one that looks past corporate formalities to the substance of what is being acquired. The question is no longer where the company sits; it is where the technology was born.
Manus was founded in 2022 by Chinese nationals Xiao Hong and Ji Yichao. The company launched an AI agent in March 2025 that gained rapid attention for its ability to perform complex tasks on top of existing large language models. Unlike many Chinese AI firms, Manus did not build its own foundation model; instead it created an agent framework that could operate with third‑party models.
In mid‑2025 Manus moved its headquarters and about 40 core technical staff from China to Singapore, while roughly 80 employees in China were laid off. The relocation was described by analysts as “Singapore washing.” Meta announced the acquisition in December 2025 and closed the deal shortly thereafter. Neither Manus nor Meta sought Chinese regulatory approval for the relocation or the acquisition.
The Ministry of Commerce opened an investigation in January 2026, shortly after the transaction closed. In March, Manus co‑founders were summoned to Beijing and barred from leaving the country. On April 27, the NDRC issued a formal prohibition order, stating that it would “prohibit foreign investment in the Manus project in accordance with laws and regulations, and has required the parties involved to withdraw the acquisition transaction.” By June, Meta had begun dismantling the deal, halting data sharing and completing an operational separation.
The NDRC’s decision was based on the 2021 Measures for the Security Review of Foreign Investment. Rather than focusing on the legal entity, the commission referred to the “project” and examined where the technology was developed, where the engineering talent was trained, and how intellectual property was transferred out of the original Chinese entity. The order did not claim that Manus was currently operating in China, nor that the technology was subject to an existing export control. Instead, the enforcement rested on the premise that technology created by Chinese nationals on Chinese soil retains a regulatory nexus to China, regardless of subsequent redomiciling or ownership changes.
The Manus case signals a shift toward a “technological nationality” doctrine. Analysts note that Singapore incorporation, Cayman Islands registration, or Delaware incorporation no longer guarantees immunity from Chinese regulatory reach. For in‑house counsel, the lesson is that redomiciling does not extinguish Chinese jurisdiction. Corporate restructuring does not sever the regulatory nexus. If core technology was developed in China or by Chinese nationals who acquired their expertise domestically, Beijing has now demonstrated both the willingness and the mechanism to reach across borders and unwind the transaction after the fact.
The new regulatory framework codified this principle. On June 1 2026, the State Council issued the Regulation on Outbound Investment (State Council Decree No. 837), effective July 1. Article 13 specifically prohibits investors from exporting, using, or transferring goods, technologies, services, or data prohibited from export, including indirect means such as relocating technical personnel overseas, providing cross‑border technical guidance, and arranging overseas training programs. The regulation introduces what commentators call “full‑process supervision,” meaning regulators are concerned not only with market entry or deal consummation but with ongoing operations, risk exposure, and conduct compliance throughout an investment’s lifetime.
The regulation also establishes an outbound investment security review mechanism that mirrors the inbound FISR, giving Beijing statutory authority to punish foreign firms whose home countries restrict Chinese investment. Consequently, a U.S. acquirer of Chinese‑origin AI may trigger review both as an inbound foreign investment under the FISR and as a restricted outbound investment under the new State Council regulation. The compliance question is no longer whether one jurisdiction objects; it is whether either jurisdiction has grounds to act.
For U.S. entities, the Outbound Investment Rule (Executive Order 14105, codified at 31 C.F.R. Part 850) restricts U.S. persons from making covered investments in entities involving Chinese persons in AI‑related sectors. On the Chinese side, the 2025 Catalogue of Technologies Prohibited or Restricted from Export lists core AI techniques, including large‑scale personalized recommendation algorithms. The Manus case demonstrates that both sides can act, creating a dual regulatory exposure.
The unwind of the Manus deal is not an isolated enforcement action but establishes a new baseline. Beijing has demonstrated that it will reach through offshore structures, past corporate reorganizations, and beyond national borders to assert authority over technology it considers Chinese in origin. The new State Council regulation ensures that this authority is not ad hoc. It is statutory, prospective, and enforceable at every stage of an investment’s lifecycle.
For in‑house counsel, the practical takeaway is that any AI‑related transaction touching Chinese‑origin technology, talent, or data now requires a different diligence framework, one that looks past corporate formalities to the substance of what is being acquired. The question is no longer where the company sits; it is where the technology was born.
